Clinical Trials in Pittsburgh

Showing 19121-19140 of 21,047 trials

The Effect of Neuromuscular Electrical Stimulation (NMES)

NCT00765739

The purpose of this project is to test the effectiveness of neuromuscular electrical stimulation (NMES) that produces 40 % of maximum voluntary contraction (MVC) in increasing muscle size and improvement in muscle force output within the thigh muscle of elderly people.

Muscle Fiber Atrophy, Type II

University of Pittsburgh23 participantsStarted Oct 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?

NCT00032357

Veterans Affairs Cooperative Study #410, The Iron and Atherosclerosis Trial, FeAST, a 24-hospital prospective randomized single-blinded clinical trial of graded iron reduction was conducted between May 1, 1999 and April 30, 2005, and has now been completed. A total of 1,277 primarily male participants with peripheral arterial disease were entered. The primary outcome was all cause mortality and the secondary outcome combined death plus non-fatal myocardial infarction (MI) and stroke.

AtherosclerosisIntermittent ClaudicationPeripheral Vascular Diseases

US Department of Veterans Affairs1,277 participantsStarted May 1999

Birmingham, Alabama, United States • No. Little Rock, Arkansas, United States • Long Beach, California, United States +21 more locations

The Effect of Neuromuscular Electrical Stimulation (NMES)

Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?

Find Trials by Condition in Pittsburgh

Invasive Fungal Infections Surveillance Initiative

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Rollover Protocol for Prior SU011248 Protocols

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

A Long-Term, Open-Label, Study on Schizophrenia

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

HIV and Hepatitis Care Coordination in Methadone Treatment

Pediatric Nasal Mask Usability Study